Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation | MicrobiomeTrials← Back to trialsNCT07099638
Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-09Est. Completion: 2029-06-01
Enrollment target: 496 participants Locations- TSET Health Promotion Research Center, Oklahoma City, Oklahoma, United States
Other microbiome trials you might be interested in
PTSD
Veterans with posttraumatic stress disorder (PTSD) need more effective treatments. Existing options can have limited adh…
Palo Alto, United StatesEst. completion Sep 30, 2030
Smoking
Background: It is important to quickly identify when people are at risk of smoking. Most current methods rely on people …
Kansas City, United StatesCompleted Apr 30, 2027